ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 26 filers reported holding ENLIVEX THERAPEUTICS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lee Capital Holdings LLC | 11,805 | $46,482 | 0.07% |
Susquehanna International Group Ltd. | 18,887 | $72,073 | 0.03% |
Compagnie Lombard Odier SCmA | 50,000 | $190,000 | 0.01% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 13,000 | $50,700 | 0.00% |
WELLS FARGO & COMPANY/MN | 11,746 | $46,250 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
UBS Group AG | 33,445 | $131,774 | 0.00% |
Sargent Bickham Lagudis LLC | 15 | $59 | 0.00% |
GOLDMAN SACHS GROUP INC | 18,908 | $74,450 | 0.00% |
OSAIC HOLDINGS, INC. | 400 | $2,000 | 0.00% |